缩写名/全名 |
MOL PHARMACEUT
MOLECULAR PHARMACEUTICS |
||||||||||||||||||||||||
ISSN号 | 1543-8384 | ||||||||||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||||||||||
影响因子 | 2015:4.342, 2016:4.44, 2017:4.556, 2018:4.396, 2019:4.321, | ||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||||||
年文章数 | 483 | ||||||||||||||||||||||||
出版年份 | 2004 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 平均2.0个月 |
||||||||||||||||||||||||
录用比例 | 约50% | ||||||||||||||||||||||||
投稿链接 | https://acs.manuscriptcentral.com/acs | ||||||||||||||||||||||||
投稿官网 | http://pubs.acs.org/journal/mpohbp | ||||||||||||||||||||||||
h-index | 110 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1543-8384%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Author: Qiu F, Meng T, Chen Q1, Zhou K, Shao Y2, Matlock G, Ma X, Wu W, Du Y, Wang X, Deng G3, Ma JX, Xu Q. Journal: Mol Pharm. 2019 May 6;16(5):1958-1970. doi: 10.1021/acs.molpharmaceut.8b01319. Epub 2019 Mar 26. PubMed DOI |
2. | Rattle-Type Gold Nanorods/Porous-SiO2 Nanocomposites as Near-Infrared Light-Activated Drug Delivery Systems for Cancer Combined Chemo-Photothermal Therapy. Author: Yu Y1, Zhou M1, Zhang W1, Huang L2, Miao D1, Zhu H1, Su G1. Journal: Mol Pharm. 2019 May 6;16(5):1929-1938. doi: 10.1021/acs.molpharmaceut.8b01298. Epub 2019 Apr 4. PubMed DOI |
3. | Synthesis and Bioevaluation of Novel [18F]FDG-Conjugated 2-Nitroimidazole Derivatives for Tumor Hypoxia Imaging. Author: Yang X1,2, Wang F3, Zhu H4, Yang Z4, Chu T3. Journal: Mol Pharm. 2019 May 6;16(5):2118-2128. doi: 10.1021/acs.molpharmaceut.9b00075. Epub 2019 Apr 19. PubMed DOI |
4. | Targeted Delivery of Zoledronate to Tumor-Associated Macrophages for Cancer Immunotherapy. Author: Zang X1, Zhang X1, Hu H1, Qiao M1, Zhao X1, Deng Y1, Chen D1. Journal: Mol Pharm. 2019 May 6;16(5):2249-2258. doi: 10.1021/acs.molpharmaceut.9b00261. Epub 2019 Apr 22. PubMed DOI |
5. | Highly Selective Protein Tyrosine Phosphatase Inhibitor, 2,2',3,3'-Tetrabromo-4,4',5,5'-tetrahydroxydiphenylmethane, Ameliorates Type 2 Diabetes Mellitus in BKS db Mice. Author: Li C1,2,3,4, Luo J1,2,3,4, Guo S1,2,3, Jia X1,2,3, Guo C1,2,3,4, Li X1,2,3, Xu Q1,2,3,4, Shi D1,2,3,4,5. Journal: Mol Pharm. 2019 May 6;16(5):1839-1850. doi: 10.1021/acs.molpharmaceut.8b01106. Epub 2019 Apr 18. PubMed DOI |
6. | Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application. Author: Ma X1, Kang X, He L, Zhou J, Zhou J, Sturm MB, Beer DG, Kuick R, Nancarrow DJ2, Appelman HD, Pang Z, Li W, Zhang C, Zhang W, Zhang Y, Wang TD, Li M. Journal: Mol Pharm. 2019 May 6;16(5):2199-2213. doi: 10.1021/acs.molpharmaceut.9b00185. Epub 2019 Apr 18. PubMed DOI |
7. | Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles. Author: Huang X1, Wu J1, He M1, Hou X1, Wang Y1, Cai X1, Xin H2, Gao F3,1,4, Chen Y3,1,4. Journal: Mol Pharm. 2019 May 6;16(5):2172-2183. doi: 10.1021/acs.molpharmaceut.9b00119. Epub 2019 Apr 12. PubMed DOI |
8. | Positron Emission Tomography Imaging of Platelet-Derived Growth Factor Receptor β in Colorectal Tumor Xenograft Using Zirconium-89 Labeled Dimeric Affibody Molecule. Author: Cai H1, Shi Q2, Tang Y3, Chen L4, Chen Y5, Tao Z2, Yang H2, Xie F6, Wu X1, Liu N5, Yang Y4, Wu H7, Tian R1, Lu X2, Li L1. Journal: Mol Pharm. 2019 May 6;16(5):1950-1957. doi: 10.1021/acs.molpharmaceut.8b01317. Epub 2019 Apr 24. PubMed DOI |
9. | Small Molecular Theranostic Assemblies Functionalized by Doxorubicin-Hyaluronic Acid-Methotrexate Prodrug for Multiple Tumor Targeting and Imaging-Guided Combined Chemo-Photothermal Therapy. Author: Chen Y1, Chen Q1, Zhu Q1, Liu J1, Li Y2,3, Gao X1, Chen D1, Zhu X1. Journal: Mol Pharm. 2019 Apr 30. doi: 10.1021/acs.molpharmaceut.9b00072. [Epub ahead of print] PubMed DOI |
10. | Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer. Author: Cao A1, Ma P2, Yang T1, Lan Y1, Yu S1, Liu L1, Sun Y1, Liu Y1,3. Journal: Mol Pharm. 2019 Apr 30. doi: 10.1021/acs.molpharmaceut.9b00094. [Epub ahead of print] PubMed DOI |
|
|